Katherine Collins - February 19, 2025 Revolutionising Immunotherapy: The Promise of TCR T-Cells For the past 10 years or so, the focus in the adoptive T-cell therapy space has been on chimeric ...
Anna Mudge - October 29, 2024 GENE-ius options to protect gene therapies Gene therapies involve treating patients by manipulating their genetic makeup. Such therapies may ...
Adam Gregory - August 13, 2024 ‘It’s a 50% reduction in ageing’ Singapore startup VVB Bio promises a dramatic reduction in ageing via a single jab. Now out of ...
Katherine Collins - April 2, 2024 Efficiency in Expansion: Meeting the Scale-Up Challenge in Cell and Gene Therapies One of the pivotal challenges in the development and commercialisation of cell and gene therapies ...
Nick Sutcliffe - March 4, 2024 Cellular Agriculture – Innovating through the Challenges The last year (2023) has seen a difficult environment for Cellular Agriculture (Cell Ag) companies ...
Katie Dale - February 26, 2024 Top marks for Iovance as FDA approves first-in-class cell therapy Amtagvi for solid tumours On February 16, 2024, a real milestone was reached in the cell therapy field, as the FDA approved ...
Katie Dale - November 6, 2023 Swapping in stem cells for diabetes treatment With just under 50% of type 1 diabetes patients using wearable blood glucose monitors1, medical ...
Fay Allen - August 10, 2023 In vivo expression of chimeric antigen receptors: using gene therapy to improve cell therapy In vivo CAR therapies build on the success of standard CAR treatments and aim to overcome the ...
Ine Vanderleyden - August 9, 2023 The next-generation therapies for autoimmune diseases The immune system has an extraordinary capacity to distinguish “self” from “non-self”. This means ...
Edward Couchman - August 7, 2023 Cells as medicines: the promise of cell therapy Cell therapy is one of the most exciting areas of medical science, with recent years having seen ...
Nick Sutcliffe - July 26, 2023 IP priorities for forward-looking cell and gene therapy businesses IP priorities are especially important to businesses developing advanced therapeutic products. ...
Anna Mudge - May 4, 2023 The allogeneic advantage Bespoke cell therapies are expensive and time-consuming. Now allogeneic cell treatments offer a ...
Anna Mudge - March 21, 2023 Advanced Therapies Congress 2023 - five key themes Anna Mudge enjoyed a bustling two days at the Advanced Therapies Congress 2023 in London. Nine ...
Ine Vanderleyden - February 20, 2023 Trafficking T cells – how to get cells to their target destination After being in the shadow of its famous relative, the antibody-producing B cell, for many decades, ...
Katie Dale - January 21, 2023 CAR Treg cell therapy - to autoimmunity and beyond A new wave of cell therapy is hitting the clinics for treating various autoimmune diseases, by ...
Katherine Collins - December 23, 2022 A world-first approval for off-the-shelf cell therapy We are delighted to learn that this week the European Commission granted the world’s first approval ...
Fay Allen - March 8, 2022 We need to talk about women's health - spotlight on endometriosis Women’s health is an area that has suffered from gender bias for years. One reason for this is that ...
Daniel Yin - July 28, 2021 Senolytics are knock, knock, knocking on ageing’s door In 1974, Bob Dylan asked that we stay forever young. Today, exciting developments in the longevity ...
Joseph Morgan - July 19, 2021 First human in vivo CRISPR/Cas9 gene editing results make history The ability to directly edit a patient’s genome safely and efficiently to treat genetic diseases ...
Edward Couchman - June 15, 2021 Cell therapy: repairing and rebuilding the body Recent advances in medicine have, for the first time, allowed physicians to directly intervene in ...
Adam Gregory - April 19, 2021 Jim Mellon: the reluctant gradualist taking on ageing Forward editor Caitlin Mackesy Davies learns how we might all be able to live long and prosper from ...
Isobel Stone - April 7, 2021 Need to know: are we set for a bioprinting boom? From refashioning foods to fabricating organs, bioprinting is the smart technology that could have ...
Lucy White - March 31, 2021 The future of organ transplantation: growing organs from scratch? Organ transplantation has saved, transformed, and extended countless lives. Although ...
Frances Salisbury - September 10, 2020 Neoantigens: IP considerations for an emerging class of cancer immunotherapy Recent cell and gene therapy product approvals have allowed the pharmaceutical industry to start a ...
Rebecca Tollervey - June 25, 2020 Cellular immunity – a contributor to COVID-19 “dark matter”? Immunologist Karl Friston of University College London has theorized that there may be ...
Ine Vanderleyden - March 31, 2020 Neoantigen-targeted adoptive cell therapies – the next frontier in cancer immunotherapy Cancer immunotherapies harness the power of the patient’s immune system to destroy malignant cells ...
Eliot Ward - December 6, 2019 Gamma/delta T cells emerge as an untapped resource for cancer immunotherapy Third lymphocyte lineage shows its mettle B lymphocytes, a type of white blood cell that is ...
Adam Gregory - September 26, 2019 T cell engagers - dark horses of immunotherapy Chimeric antigen receptor (CAR) technology has attracted a lot of attention and investment in ...
